
Loon provides AI-driven tools to de-risk the commercialization of health technologies by forecasting market access and reimbursement. Using proprietary Cognitive Ensemble AI Systems and Agentic AI tools, it performs scenario simulation and quantifies risk to optimize HTA value demonstrations and HEOR timelines. Its end-to-end AI evidence synthesis and market access forecasting services are HTA-grade and fully validated by experts. Loon serves sponsors, HTA bodies, CROs, policymakers, and market access consultancies with vendor-agnostic, SaaS and AI-agent-as-a-Service offerings. The company targets faster reimbursement decisions, expanded payer acceptance, and scalable evidence generation for health technology launches.

Loon provides AI-driven tools to de-risk the commercialization of health technologies by forecasting market access and reimbursement. Using proprietary Cognitive Ensemble AI Systems and Agentic AI tools, it performs scenario simulation and quantifies risk to optimize HTA value demonstrations and HEOR timelines. Its end-to-end AI evidence synthesis and market access forecasting services are HTA-grade and fully validated by experts. Loon serves sponsors, HTA bodies, CROs, policymakers, and market access consultancies with vendor-agnostic, SaaS and AI-agent-as-a-Service offerings. The company targets faster reimbursement decisions, expanded payer acceptance, and scalable evidence generation for health technology launches.